Artificial Intelligence for Nanomedicine

Aim

Our goal is to create the platform for rapid development of personalized nanomedicine drug delivery systems. We intend to do it by developing the intellectual property  of EVO-NANO results in accordance to market and regulatory demands.

Origins

We build upon the computational platform that is under development in H2020 FET-Open project EVO-NANO.  The platform uses AI to generate and in silico test novel cancer treatments.

Objectives

1

IP Positioning

2

Macro Market Analysis

3

Application Analysis

4

Market Strategy

5

Exploitation